Astria Therapeutics, Inc. (ATXS) has 5 open-market insider trades by 4 insiders since 2021. The most active filer is Perceptive LIFE Sciences Master FUND Ltd., Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Perceptive Xontogeny Venture Fund, LP | Dir | — | 1 | $60.0M | 2024-02-01 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | Dir | — | 2 | $34.0M | 2023-10-16 |
| Perceptive Advisors LLC | Dir | — | 1 | $4.6M | 2023-12-21 |
| Andrew Komjathy | Chief Commercial Officer | — | 1 | $670 | 2026-01-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Christopher Morabito | — | Sell | $136K | 2024-04-01 |
| Perceptive Xontogeny Venture Fund, LP | Director | Buy | $60.0M | 2024-02-01 |
| Christopher Morabito | — | Sell | $111K | 2024-01-26 |
| Perceptive Advisors LLC | Director | Buy | $4.6M | 2023-12-21 |
| Perceptive LIFE Sciences Master FUND Ltd. | Director | Buy | $14.0M | 2023-10-16 |
| Perceptive LIFE Sciences Master FUND Ltd. | Director | Buy | $20.0M |
Companies that share insiders with ATXS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-12-19 |
| Andrew Komjathy | Chief Commercial Officer | Buy | $670 | 2021-11-19 |